GE Capital supplies $10M term loan facility to InfraReDx

GE Capital, Healthcare Financial Services has announced that it is the sole lender on a $10 million senior secured multidraw term loan to Burlington, MA-based InfraReDx. The financing will be used to help support commercialization efforts for its heart disease imaging system.

InfraReDx's TVC imaging system (pictured) is the only multimodality device to combine intravascular ultrasound and near-infrared spectroscopy. The system, which is FDA-cleared for the detection of lipid core plaques of interest, was recently profiled at the annual Transcatheter Cardiovascular Therapeutics Meeting in San Francisco.

"We've worked with GE Capital in the past so they are highly knowledgeable about our business and industry," said Donald Southard, InfraReDx's president and CEO. "This expertise was essential in structuring a financing solution commensurate with the company's immediate and longer term growth objectives."

- get more from the GE Capital release

Suggested Articles

AI-based drug molecule designer XtalPi has secured a mammoth funding round totaling $318.8 million, from global banking and tech investors.

LabCorp has licensed a blood test from Genfit designed to identify patients with risky cases of the liver disease NASH.

Philips has launched a compact, single-use device for physically clearing potentially dangerous blood clots lodged in the arms and legs.